Advancd non-small cell lung cancer

 
       
  • 晚期非小细胞肺癌

Advancd non-small cell lung cancer的用法和样例:

例句

  1. Monzo M, Rosell R, Taron M. Drug resistance in non small cell lung cancer. Lung Cancer,2001,34 Suppl 2 : S91-S94.
    [韩宝惠
  2. Gemcitabine is a new active drug in the treatment of advanced non small cell lung cancer (NSCLC).
    吉西他滨是近年来治疗晚期非小细胞肺癌的有效新药。
  3. Purpose:To compare the therapeutic effects of VP and MVP regimen for the treatment of non small cell lung cancer(NSCLC).
    目的:比较VP方案与MVP方案对非小细胞肺癌(NSCLC)的治疗效果。
  4. OBJECTIVE:To study the clinical significance of BCG PSN combined with operation or chemotherapy in treating non small cell lung cancer(NSCLC).
    目的 :探讨卡介菌核糖核酸 (BCG PSN)与手术或化疗联合治疗非小细胞肺癌 (non smallcelllungcancer ,NSCLC)的临床意义。
  5. Objective To investigate the correlation between BRI gene expression and the metastatic potential in human non small cell lung cancer cell lines.
    目的 研究BRI基因在人非小细胞肺癌细胞系中的表达 ,探讨其表达情况与肺癌转移能力的相关性。
  6. Objective To study the expression of survivin and its relationship with expression of P53,c myc,k ras in non small cell lung cancer(NSCLC).
    目的 探讨survivin基因在非小细胞肺癌 (NSCLC)中的表达 ,及与P5 3、c myc、k ras蛋白表达的相互关系。

Advancd non-small cell lung cancer的海词问答与网友补充:

提问补充

Advancd non-small cell lung cancer的相关资料:

临近单词

目录
应用 附录 查词历史
    更多>>今日热词